SCOPUS 정보 검색 플랫폼

Cell Cycle

Volumn 16, Issue 1, 2017, Pages 3-4

Killing AML: RIPK3 leads the way

(3) Höckendorf, Ulrike a Yabal, Monica a Jost, Philipp J a

a TECHNICAL UNIVERSITY OF MUNICH (Germany)

Author keywords

AML; inflammasome; leukemia initiating cells; regulated necrosis; RIPK3

Indexed keywords

FLT3 LIGAND; PROTEIN; PROTEIN MLKL; PROTEIN SERINE THREONINE KINASE; RECEPTOR INTERACTING SERINE THREONINE KINASE 3; UNCLASSIFIED DRUG; INFLAMMASOME; RECEPTOR INTERACTING PROTEIN SERINE THREONINE KINASE;

ACUTE MYELOID LEUKEMIA; ADOPTIVE TRANSFER; APOPTOSIS; BONE MARROW CELL; BONE MARROW TRANSPLANTATION; CELL DEATH; ENZYME ACTIVATION; ENZYME INHIBITION; GENE EXPRESSION; HUMAN; LEUKEMIA CELL; NOTE; ANIMAL; BIOLOGICAL MODEL; CANCER STEM CELL; ENZYMOLOGY; GENETICS; METABOLISM; PATHOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; APOPTOSIS; HUMANS; INFLAMMASOMES; LEUKEMIA, MYELOID, ACUTE; MODELS, BIOLOGICAL; NEOPLASTIC STEM CELLS; RECEPTOR-INTERACTING PROTEIN SERINE-THREONINE KINASES; SIGNAL TRANSDUCTION;

EID: 84992051956 PISSN: 15384101 EISSN: 15514005 Source Type: Journal
DOI: 10.1080/15384101.2016.1232069 Document Type: Note

Times cited : (3)

References (7)

1
- 84894245627
- 24522528 , Zandi S, Mitchell A, Chen WC, Brandwein JM, Gupta V, Kennedy JA, Schimmer AD, Schuh AC, Yee KW, et al.; PMID:;
- Shlush LI, Zandi S, Mitchell A, Chen WC, Brandwein JM, Gupta V, Kennedy JA, Schimmer AD, Schuh AC, Yee KW, et al. Identification of pre-leukaemic haematopoietic stem cells in acute leukaemia. Nature 2014; 506:328-33; PMID:24522528; http://dx.doi.org/10.1038/nature13038
- (2014) Identification of pre-leukaemic haematopoietic stem cells in acute leukaemia. Nature , vol.506 , pp. 328-333
- Shlush, L.I.¹

2
- 84867490138
- 23063124 , Ryan J, Carrasco R, Neuberg D, Rossi DJ, Stone RM, DeAngelo DJ, Frattini MG, Letai A; PMID:;
- Vo TT, Ryan J, Carrasco R, Neuberg D, Rossi DJ, Stone RM, DeAngelo DJ, Frattini MG, Letai A. Relative mitochondrial priming of myeloblasts and normal HSCs determines chemotherapeutic success in AML. Cell 2012; 151:344-55; PMID:23063124; http://dx.doi.org/10.1016/j.cell.2012.08.038
- (2012) Relative mitochondrial priming of myeloblasts and normal HSCs determines chemotherapeutic success in AML. Cell , vol.151 , pp. 344-355
- Vo, T.T.¹

3
- 84903480849
- 24882010 , Müller N, Adler H, Knies N, Groß CJ, Damgaard RB, Kanegane H, Ringelhan M, Kaufmann T, Heikenwälder M, Strasser A, et al.; PMID:;
- Yabal M, Müller N, Adler H, Knies N, Groß CJ, Damgaard RB, Kanegane H, Ringelhan M, Kaufmann T, Heikenwälder M, Strasser A, et al. XIAP restricts TNF- and RIP3-dependent cell death and inflammasome activation. Cell reports 2014; 7:1796-808; PMID:24882010; http://dx.doi.org/10.1016/j.celrep.2014.05.008
- (2014) XIAP restricts TNF- and RIP3-dependent cell death and inflammasome activation. Cell reports , vol.7 , pp. 1796-1808
- Yabal, M.¹

4
- 84979732790
- 27411587 , Yabal M, Herold T, Munkhbaatar E, Rott S, Jilg S, Kauschinger J, Magnani G, Reisinger F, Heuser M, et al.; PMID:;
- Höckendorf U, Yabal M, Herold T, Munkhbaatar E, Rott S, Jilg S, Kauschinger J, Magnani G, Reisinger F, Heuser M, et al. RIPK3 restricts myeloid leukemogenesis by promoting cell death and differentiation of leukemia initiating cells. Cancer cell 2016; 30:75-91; PMID:27411587; http://dx.doi.org/10.1016/j.ccell.2016.06.002
- (2016) RIPK3 restricts myeloid leukemogenesis by promoting cell death and differentiation of leukemia initiating cells. Cancer cell , vol.30 , pp. 75-91
- Höckendorf, U.¹

5
- 84912106351
- 25459880 , Berger SB, Pillay S, Moriwaki K, Huang C, Guo H, Lich JD, Finger J, Kasparcova V, Votta B, et al.; PMID:;
- Mandal P, Berger SB, Pillay S, Moriwaki K, Huang C, Guo H, Lich JD, Finger J, Kasparcova V, Votta B, et al. RIP3 induces apoptosis independent of pronecrotic kinase activity. Molecular cell 2014; 56:481-95; PMID:25459880; http://dx.doi.org/10.1016/j.molcel.2014.10.021
- (2014) RIP3 induces apoptosis independent of pronecrotic kinase activity. Molecular cell , vol.56 , pp. 481-495
- Mandal, P.¹

6
- 84969595271
- , Ma C, Lalaoui N, Nguyen N-Y, Navarro M, Tanzer MC, Richmond J, Ghisi M, Salmon JM, Silke N, et al.;
- Brumatti G, Ma C, Lalaoui N, Nguyen N-Y, Navarro M, Tanzer MC, Richmond J, Ghisi M, Salmon JM, Silke N, et al. The caspase-8 inhibitor emricasan combines with the SMAC mimetic birinapant to induce necroptosis and treat acute myeloid leukemia. Science translational medicine 2016; 8:339ra69; http://dx.doi.org/10.1126/scitranslmed.aad3099
- (2016) The caspase-8 inhibitor emricasan combines with the SMAC mimetic birinapant to induce necroptosis and treat acute myeloid leukemia. Science translational medicine , vol.8 , pp. 339ra69
- Brumatti, G.¹

7
- 84958646766
- 26859455 , Hänggi K, Brumatti G, Chau D, Nguyen N-YN, Vasilikos L, Spilgies LM, Heckmann DA, Ma C, Ghisi M, et al.; PMID:
- Lalaoui N, Hänggi K, Brumatti G, Chau D, Nguyen N-YN, Vasilikos L, Spilgies LM, Heckmann DA, Ma C, Ghisi M, et al. Targeting p38 or MK2 enhances the anti-leukemic activity of Smac-mimetics. Cancer cell 2016; 29:145-58; PMID:26859455; http://dx.doi.org/10.1016/j.ccell.2016.01.006
- (2016) Targeting p38 or MK2 enhances the anti-leukemic activity of Smac-mimetics. Cancer cell , vol.29 , pp. 145-158
- Lalaoui, N.¹

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.